# OnCo record rtog-0617 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/rtog-0617/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "rtog-0617", "NCT00533949" ;
  schema:name "RTOG 0617"@en ;
  schema:description "RTOG 0617 is the trial that stopped dose escalation in lung cancer: patients given 74 Gy lived shorter than those given the standard 60 Gy, and cetuximab added nothing."@en ;
  schema:url <https://onco.cc/trials/rtog-0617/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT00533949>, <https://doi.org/10.1016/S1470-2045(14)71207-0> ;
  onco:status "negative" ;
  onco:tag "radiation-wave2" ;
  onco:phase "3" ;
  schema:startDate "2007-11" ;
  onco:cancers <https://onco.cc/cancers/nsclc/> ;
  onco:technologies <https://onco.cc/technologies/imrt-igrt/>, <https://onco.cc/technologies/radiosensitisers/> ;
  onco:drugs <https://onco.cc/drugs/cetuximab/>, <https://onco.cc/drugs/carboplatin/>, <https://onco.cc/drugs/paclitaxel/> ;
  onco:companies <https://onco.cc/companies/nrg-oncology/> ;
  onco:terms <https://onco.cc/terms/chemoradiation/>, <https://onco.cc/terms/organs-at-risk/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-rtog-0617-lancet-oncol-2015/> .